Extracellular superoxide dismutase (SOD3), a secretory copper enzyme, plays an important role in atherosclerosis and hypertension by modulating the levels of extracellular superoxide anion (O 2
anchored to the extracellular matrix and endothelial cell surface through binding to the heparan sulfate proteoglycan, collagen, and fibulin-5 (3) (4) (5) . Because of its extracellular location, SOD3 plays an important role in regulating blood pressure and endothelial function by modulating the levels of extracellular O 2
•-and nitric oxide bioactivity in the vasculature (3, 6, 7) . Recently, the R213G polymorphism in the SOD3 gene, which reduces binding to endothelial surface and increases serum SOD3 levels, has been linked to an increase in cardiovascular risk (8) .
SOD3 is a secretory copper-containing enzyme with a similar active site to that of the SOD1. It has been shown that the SOD activity of both wild-type SOD1 and SOD3 depends critically on the presence of the copper ion at its native metal binding sites (9) (10) (11) . Indeed, the mechanism of scavenging O 2 •-by SOD involves alternate reduction and reoxidation of the copper ion at the active site of the enzyme. Under physiological conditions, the level of intracellular free copper is extraordinarily restricted (12) . Thus, SOD1 obtains its catalytic copper ion through interaction with the cytosolic carrier protein CCS (copper chaperone for SOD1) (13, 14) . In contrast, the cytosolic copper chaperone Atox1, not CCS, is required for full activation of SOD3 (11) . Note that SOD3 secretes through endoplasmic reticulum-Golgi pathway where Atox1 does not exist. Thus, the cytosolic Atox1 itself is required, but not sufficient for delivering copper to SOD3 protein to regulate its full activity.
Menkes ATPase (ATP7A, MNK) plays a key role in copper transport from the cytosol into the secretory pathways (15, 16) . A loss-of-function X-linked mutation of MNK leads to Menkes disease, a disorder characterized by the marked decrease in copper levels in most tissues except for the kidney and small intestine. Menkes patients show multiple abnormalities secondary to deficiencies in the activity of some secretory copper enzymes, such as dopamine β-monooxygenase (neurological abnormalities), tyrosinase (hypopigmentation), and lysyl oxidase (vascular abnormalities and connective tissue abnormalities), leading to death in infancy (16) . Importantly, immunocytochemical studies in cultured cells demonstrated that under normal concentration of copper, MNK is localized to the trans-Golgi network, where MNK delivers copper to some secretory copper enzymes (17, 18) . However, there is no information regarding whether MNK is required for delivering copper to SOD3.
In the current study, using two different MNK mutant mice with reduced copper transport function (19) (20) (21) (22) (23) (24) (25) , we provide the first evidence that MNK is highly expressed in the vasculature and that MNK is required for full activation of vascular SOD3 by transporting copper to SOD3 in the trans-Golgi network, thereby regulating O 2 •-levels in the vasculature. Of note, the copper transport to SOD3 by MNK is mediated through direct protein-protein interaction. Moreover, both MNK and SOD3 proteins are highly expressed in the intimal lesions of atherosclerotic vessels. These studies provide a novel insight into vascular MNK as a critical modulator of "superoxide" stress, which may contribute to cardiovascular disease.
MATERIALS AND METHODS

Materials, animals, and cell culture
All reagents were purchased from Sigma (St. Louis, MO), except when specified. The fibroblasts derived from male brindled MNK mutant mice, the corresponding wild-type cells (21) (22) (23) (26) . The human MNK cDNA in pWSK29 was a kind gift from Dr. Julian Mercer (Deakin University, Australia) (27) . The polyclonal antibody for SOD3 detection has been described previously (28) . Other antibodies were obtained commercially, including anti-γ-adaptin (BD Biosciences, San Jose, CA), anti-V 5 (Invitrogen, Carlsbad, CA), anti-SOD1 (BioDesign International, Kennebunk, ME), a biotin-conjugated goat anti-rabbit IgG, and anti-rabbit IgG (Bio-Rad Laboratories, Hercules, CA). C57BL/6J mice and ApoE −/− mice on a C57BL/6J background were obtained from the Jackson Laboratory (Bar Harbor, ME). The heterozygous blotchy MNK mutant mouse females and wild-type males were also obtained from Jackson Laboratory, used for establishing a colony, and maintained on regular chow. In the current study, male hemizygous mice carrying X-linked blotchy MNK mutation and control littermates were used. CHO cells stably expressing SOD3 were maintained as described previously (5) . Experiments were performed with 1% serum with no additives. Transient transfection of human MNK cDNA in pWSK29 into CHO cells was performed using the PolyFect transfection reagent (Qiagen, Valencia, California) according to the manufacturer's recommendations.
Western blot analysis
Western blot analysis was performed as described previously (28) . The primary antibodies used included a rabbit polyclonal antibody against murine SOD3 (28), a sheep antibody against human SOD1, and rabbit polyclonal antisera to MNK. Equal loading of proteins was confirmed by Ponceau or Coomassie blue staining.
SOD activity assays
SOD activity was assayed by monitoring inhibition of the rate of xanthine/xanthine oxidasemediated reduction of cytochrome c as described previously (28) . Con A-Sepharose chromatography (Amersham Biosciences, Piscataway, NJ) was used to isolate SOD3 from vessels of MNK mutant mice and their control littermates and the conditioned culture media of MNK mutant and wild-type cells as described previously (11, 28) .
Cu
2+ affinity chromatography
The Cu 2+ affinity of SOD3 in the conditioned culture medium from MNK mutant and wild-type cells was assessed as previous described (29) . Briefly, copper affinity column was prepared using a 1 ml HiTrap chelating column (Amersham Biosciences), and copper was coupled to the columns by applying 0.1 M CuCl 2 . Excess metal was then removed from each column using equilibrated buffer (20 mM Tris Cl and 0.5 M NaCl, pH 7.2). The sample was then loaded onto each copper-bound column, followed by washing thoroughly with equilibrated buffer. The copper binding proteins were eluted with increasing concentration of imidazole (0-100 mM) in the equilibrated buffer. All fractions were concentrated using Amicon Ultra-30 centrifugal filter devices (Millipore, Billerica, MA), and analyzed by Western blot analysis as described above.
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Confocal immunofluorescence analysis
For this analysis (30), we used cultured mouse fibroblasts on coverslips fixed in 4% paraformaldehyde, permeabilized in 0.1% Triton X-100, and incubated with chicken anti-MNK antibody (1:100) followed by incubation with FITC-conjugated goat antibodies to chicken IgG (1:100) (Santa Cruz Biotechnology, Santa Cruz, CA), and rabbit anti-SOD3 antibody (1:100), followed by incubation with rhodamine-conjugated goat antibodies to rabbit IgG (1:100) (Santa Cruz Biotechnology). In other experiments, cells were stained with a mouse monoclonal antibody against γ-adaptin (1:500; Santa Cruz Biotechnology), followed by a biotin-conjugated rabbit anti-murine IgG (1:200; Bio-Rad Laboratories). Cells were examined with a Bio-Rad MRC 1024 confocal microscope, using argon laser excitation lines of 488 and 514 nm with emission filters of 540/30 and 580/32 nm.
Subcellular fractionation analysis
Subcellular fractionation was performed as described previously (30) (31) (32) . Briefly, following two rinses with ice-cold PBS, confluent cells were lysed in 50 mM Tris-HCl, pH 7.5, 5 mM MgCl 2 , 25 mM KCl, 0.25 M sucrose, and a protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN). Following lysis, cells were disrupted by 20 strokes with a tight-fitting glass Dounce homogenizer, and the postnuclear supernatants were isolated by centrifugation at 500 g for 5 min. This supernatant was then subjected to discontinuous sucrose density gradient fractionation as described previously (31, 32) . A total of six fractions were collected from each gradient at the following sucrose interfaces: 0.9-1. 
Coimmunoprecipitation of SOD3 and MNK in stably transfected CHO cells and in mouse fibroblasts
Coimmunoprecipitation was performed as described previously (5).
In vitro pull down assays using recombinant SOD3 with V 5 -His tag in mouse fibroblasts
Human recombinant SOD3 with V 5 -His tag was produced in a Drosophila expression system (Invitrogen) as reported previously (11) . Mouse fibroblast cells were lysed with 500 µl of 50 mmol/l Tris-HCl buffer containing 0.1 mmol/l EDTA, 0.1 mmol/l EGTA, 1% Triton X-100, and a protease inhibitor cocktail (Roche Applied Science). For in vitro pull down assays, one microgram of recombinant SOD3 protein was incubated with mouse fibroblast cell lysates (200 μg) and 1 μg of anti-His-tag antibody (Cell Signaling Technology, Beverley, MA) overnight at 4°C with constant rocking. The immunocomplexes were captured with 20 μl of protein A/G agarose beads (Santa Cruz Biotechnology) and incubated at 4°C for 1.5 h. Immunoprecipitates were separated using SDS-PAGE and transferred to nitrocellulose membranes, and immunoblotted with anti-MNK, anti-Na, K-ATPase, and anti-V5 antibody.
Measurements of vascular superoxide production in aortas from MNK mutant mice and control littermates
Animals were killed by CO 2 inhalation. The aortas were rapidly removed and placed into chilled modified Krebs/HEPES buffer (composition in mmol/l: NaCl 99.01, KCl 4.69, CaCl 2 2.50, MgSO 4 1.20, KH 2 PO 4 1.03, NaHCO 3 25.0, Na-HEPES 20.0, and glucose 5.6; pH 7.4), cleaned of excessive adventitial tissue, and cut into 4-to 5-mm ring segments with care taken not to injure the endothelium. Vascular O 2
•-production was determined using lucigenin-enhanced chemiluminescence as described previously. (33) This method has been validated for O 2
•-measurements in vascular tissue when low concentrations of lucigenin (5 µmol/l) are used (34) .
As a second approach to measure ROS production in vessels in situ, frozen cross-sections of aortas were stained with dihydroethidium (Molecular Probes, Eugene, OR) using a previously validated method (5).
Immunohistochemical analysis
Tissues were embedded in OCT (Miles Laboratories, Elkhart, IN) and frozen using liquid nitrogen. Cryosections were stained with either a rabbit polyclonal antibody against murine SOD3 (1:10,000) (28) or a rabbit polyclonal antibody against human MNK (1:100) (22), followed by a biotin-conjugated goat anti-rabbit IgG (1:100; Bio-Rad Laboratories). Staining was developed using the ABC-AP Kit (Vector Laboratories, Burlingame, CA).
Statistical analysis
All data are expressed as mean ± SE. Data were compared between groups of cells and animals by t test when one comparison was performed or by ANOVA for multiple comparisons. When significance was indicated by ANOVA, the Tukey-Kramer post hoc test was used to specify between group differences. Values of P < 0.05 were considered statistically significant.
RESULTS
Specific activity of SOD3 is decreased in cultured MNK mutant mouse fibroblasts
Although the tissue expression of MNK is known to be widespread, its expression in the vasculature is not available. As shown in Fig. 1 , MNK was abundantly expressed in vascular smooth muscle cells, vascular endothelial cells, fibroblasts, and aorta as ~178 kDa protein that has been reported in other cells (30) .
To determine whether MNK is required for the full activity of SOD3, we used cultured brindled MNK mutant (MNK br ) mouse fibroblasts, which have a deletion of two conserved amino acids (Ala799 and Leu800) and an impairment of copper transport function (21) (22) (23) . SOD3 from the conditioned media of control and MNK mutant cells was purified using concanavalin A sepharose chromatography as described previously (11) . Activity of SOD3 in the culture medium was robustly decreased in MNK mutant fibroblasts as compared with control cells, while protein levels of SOD3 were increased ( Fig. 2A, 2B) . Thus, the specific activity of SOD3, as determined by the ratio of SOD3 activity to SOD3 protein, was markedly decreased in MNK mutant (Fig. 2C) . In contrast, the activity, protein, and specific activity of SOD1 were not changed in MNK mutant fibroblasts (Fig. 2) .
The copper affinity of SOD3, as determined by copper affinity chromatography, was not changed in MNK mutant cells, suggesting that the decrease in SOD3-specific activity in MNK mutant cells is not due to a decrease in copper affinity of SOD3 (Fig. 3A) . However, specific activity of SOD3 purified from MNK mutant cells was partially restored by addition of copper (Fig. 3B) . Although specific activity of SOD3 purified from control cells was not affected by copper addition (Fig. 3B) , it was decreased by the copper chelator BCS (bathocuproine disulfonate) (data not shown). These results suggest that most of the enzyme secreted from control cells is fully metallated. Thus, MNK is required for copper loading to SOD3 for its full activity.
Colocalization of SOD3 and MNK in the trans-Golgi network
Since we found that specific activity of SOD3 is dependent on MNK, we next examined where MNK delivers copper to SOD3 in the secretory pathway. Confocal immunofluorescence analysis showed that MNK and SOD3 partially colocalized with γ-adaptin, a trans-Golgi network resident protein, in the perinuclear region (Fig. 4A) . Furthermore, subcellular fractionation analysis demonstrated that MNK and SOD3 partially cofractionated with γ-adaptin, but not GM130, a cisGolgi resident protein (Fig. 4B) . These results suggest that SOD3 colocalizes with MNK in the trans-Golgi network of the secretory pathway.
SOD3 directly interacts with MNK in a copper-dependent manner
To determine how SOD3 obtains copper through MNK, we performed coimmunoprecipitation of SOD3 and MNK in mouse fibroblasts. As shown in Fig. 5A , SOD3 was coimmunoprecipitated with MNK, which was enhanced by addition of copper in a dose-dependent manner. In contrast, their association was inhibited by the copper chelator BCS. The interaction of SOD3 and MNK was further confirmed using CHO cells cotransfected with both proteins (Fig. 5B) . In vitro pull down assays demonstrated that interaction of SOD3 with MNK is direct and specific, because recombinant SOD3 bound to MNK protein, but not to unrelated protein Na, K, ATPase (Fig.  5C ). These data suggest that MNK directly interacts with SOD3 in a copper-dependent manner.
MNK is required for full activation of SOD3 in vascular tissue
To confirm further that MNK is required for the full activity of SOD3 in vivo, we employed aortas from MNK mutant mice and control littermates. Since male brindled MNK mutant mice die at around 15 d after birth (19), we used male mice carrying the X-linked blotchy MNK mutation (MNK blo ) which have splice site mutations with stop codon at amino acid residue 794 with impaired copper transport function, but survive more than six months of age (19, 20, 25) . Consistent with the results obtained with cultured fibroblasts from the brindled MNK mutant mice, activity of SOD3 was markedly decreased in aortas from the MNK blo mutant mice compared with those from control littermates, while protein levels of SOD3 were significantly increased (Fig. 6A, 6B) . In contrast, the activity and protein of SOD1 were not altered in aortas from MNK blo mutant mice (Fig. 6A, 6B) . Thus, the specific activity of SOD3, but not SOD1, was robustly decreased in aortas from MNK blo mutant mice (90±3.4% decrease, P<0.01) (Fig. 6C ).
Taken together, these findings indicate that loss of MNK function markedly decreased the specific activity of SOD3, but not SOD1, in vascular tissue.
Increased vascular O 2 •-production in MNK mutant mice
To determine the functional significance of MNK in modulating SOD3 activity in vivo, we measured O 2 •-production in aortas from control and MNK blo mutant mice using lucigeninenhanced chemiluminescence. We found that vascular O 2
•-was markedly increased in aortas from MNK mutant mice as compared with those from control littermates (Fig. 7A) . To estimate O 2
• -production in mouse aortas in situ, we also used the dihydroethidium (DHE) fluorescence method. DHE is a fluorescent dye that has been shown to specifically detect O 2
•-in situ (5, 35) .
DHE staining clearly demonstrated that O 2
•-production was markedly increased in all layers of aortas from MNK mutant mice (Fig. 7B) . Importantly, the fluorescence signal was markedly decreased by the addition of SOD, suggesting that the DHE signal mainly reflects an increase in O 2
•-. Taken together, these findings suggest that MNK plays an important role in regulating vascular O 2 •-levels, at least in part, by modulating vascular SOD3 activity.
MNK is highly expressed in the intimal lesions of atherosclerotic vessels
To gain further insight into the role of MNK in modulating SOD3 activity in atherosclerosis in which SOD3 expression and O 2 •-production are markedly increased (28) DISCUSSION MNK belongs to a large family of cation-transporting P-type ATPase, and plays a key role in transporting copper from the cytosol into the secretory pathways. Although MNK has been shown to be essential for full activity of some secretory copper enzymes such as tyrosinase and peptidylglycine α-amidating monooxygenase in mammalian cells (17, 18) , little is known about its role in the vasculature. Here we provide the first evidence that MNK is highly expressed in the vascular tissues and cells, and that MNK is required for full activation of the secretory copper enzyme SOD3 using cultured fibroblasts and aortas from MNK mutant mice (19, 20, 22, 23) . Of note, activation of the cytosolic copper enzyme SOD1 is MNK-independent. Copper affinity chromatography analysis showed that the decrease in SOD3-specific activity in MNK mutant cells is not due to the reduced copper affinity of SOD3. Specific activity of SOD3 purified from MNK mutant cells is partially restored by copper addition. These findings indicate that MNK plays a critical role in delivering copper to SOD3 for its full activation. However, SOD3 activity is not completely inhibited in MNK mutant cells, suggesting that MNK-independent copper delivery pathway for SOD3 may also exist. It is not clear why copper addition could not completely restore specific activity of SOD3 purified from MNK mutant cells. This might be due to the possibility that added copper is not incorporated properly into the active site of SOD3 in
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MNK mutant cells. Consistent with our results, specific activity of other secretory copper enzyme such as peptidylglycine-α-hydroxylating monooxygenase (PHM) in MNK mutant cells is less than that in wild-type cells after addition of copper (23) .
SOD3 is a secretory copper enzyme containing a classical signal peptide that will direct SOD3 from the endoplasmic reticulum through the trans-Golgi network to the plasma membrane, thereby being secreted into the extracellular space (37). Since we found that specific activity of SOD3 is dependent on MNK, we next investigated the mechanisms by which MNK delivers copper to SOD3 in the secretory pathway. Both immunofluorescence and subcellular fraction analysis revealed that SOD3 partially colocalizes with MNK and γ-adaptin, a marker of the transGolgi network, suggesting that MNK transports copper to SOD3 in the trans-Golgi network. Moreover, coimmunoprecipitation and in vitro pull down assays demonstrated that MNK directly interacts with SOD3 in vivo and in vitro. Thus, these data suggest that MNK delivers copper to SOD3 in the trans-Golgi network through direct binding to SOD3. We also found that interaction of MNK with SOD3 is copper-dependent. To our knowledge, this is the first evidence that MNK directly interacts with its target secretory copper enzyme in a copper-dependent manner. The detailed mechanisms of how SOD3 obtains copper from MNK require further investigation.
Since the level of intracellular free copper is extraordinarily restricted (12) , MNK requires cytosolic copper carrier proteins to deliver copper to SOD3 in the trans-Golgi network (38) . We have recently demonstrated that the copper chaperone Atox1 is involved in copper delivery to SOD3 (11) . There are several proteins such as MNK, WND (ATP7B), and FKBP52 (39) that receive copper from Atox1; however, it has been shown that Atox1 delivers copper to other secretory copper-containing enzymes via MNK in the yeast system (40, 41) . Thus, it is likely that SOD3 may obtain copper through Atox1-MNK pathway in the vascular cells.
To determine the functional significance of MNK in modulating SOD3 activity in vivo, we measured O 2
•-levels in aortas from control and MNK mutant mice. Lucigenin chemiluminescence and SOD inhibitable DHE fluorescence assays demonstrated that vascular O 2 •-level was significantly increased in MNK mutant mice in which vascular SOD3 activity was markedly decreased. Neither hydroxyl radical, NO
• , peroxynitrite, H 2 O 2 , hypochlorite, or singlet O 2 significantly oxidizes HE (43) . In addition, since SOD cannot enter the intracellular space, the detected SOD inhibitable DHE signal may mainly reflect the O 2
•-derived from extracellular space. Indeed, oxyethidium, a specific fluorescent product by the reaction of DHE and superoxide anion (42) , is cell-permeable (unpublished observation). These results suggest that MNK plays an essential role in modulating O 2 •-through regulating SOD3 activity in the vasculature.
NO
• exerts myriads of biological effects, including dilation of vessels, inhibition of proliferation of vascular smooth muscle cells, and platelet aggregation (44) . These properties are antiatherogenic and antihypertensive. Bioavailability of NO • can be regulated by extracellular
•− undergo an extremely rapid, diffusion limited radical/radical reaction, leading to the formation of the potent oxidant peroxynitrite anion (44) that is involved in numerous pathophysiological processes (45) . Endothelium-derived NO • must transverse the extracellular space between the endothelium and the smooth muscle to induce smooth muscle relaxation. Therefore, the increase in extracellular O 2 •− production, at least in part, due to To gain insight into the role of MNK in modulating SOD3 activity in atherosclerosis in which SOD3 expression and O 2
•-production are markedly increased, we performed immunohistochemical analysis of MNK protein in atherosclerotic aorta from ApoE −/− mice. We found that MNK protein expression was highly expressed in the intimal lesion of atherosclerosis where SOD3 was markedly expressed in the extracellular matrix (Fig. 8) . Of note, despite the specific activity of SOD3 is decreased in MNK mutant mice, the protein expression is rather increased in these mice ( Fig. 1 and 5) . We have previously shown that Atox1 functions not only as a copper chaperone but also as a positive regulator for SOD3 transcription (11) . Atox1 is also markedly increased in the intimal lesion of atherosclerosis (11), and knockdown of Atox1 by siRNA completely abolishes the increase in SOD3 protein levels in MNK mutant cells (unpublished observation). Thus, these findings suggest that the increase in SOD3 protein levels in MNK mutant cells may be due to the up-regulation of Atox1. Note that some Menkes mutant mice, where SOD3 activity is markedly decreased, show vascular abnormalities including formation of aortic aneurysm (46) , which is associated with oxidative stress (47, 48) . Thus, it is conceivable that MNK also may be involved in aortic aneurysm formation by modulating vascular redox state via regulating SOD3 activity. Studies focused on the functional role of MNK and the mechanisms of how MNK regulates SOD3 expression in atherosclerosis and other cardiovascular diseases are subjects of further investigation.
In summary, the present study demonstrates that MNK plays an essential role in regulating SOD3 activity through transporting copper to SOD3 in the trans-Golgi network, thereby modulating vascular O 2 •-levels. In the cardiovascular system, SOD3 is highly expressed in blood vessels and plays a major role in increasing nitric oxide bioactivity by scavenging extracellular O 2 •-. Thus, our study should provide a novel insight into how redox state of blood vessel is tightly controlled by copper transport systems. (21) (22) (23) . Cells were cultured in 1% serum containing DMEM for 72 h. The SOD3 secreted in the culture medium was collected and concentrated by concanavalin-A sepharose chromatography. A) Activity of SOD3 in concentrated culture medium and SOD1 in cell lysates was assayed by examining the inhibition of cytochrome c reduction by xanthine/xanthine oxidase at pH 7.4 (28) . The results are presented as mean ± SE from 4 separate experiments.
† P < 0.01 vs. control. NS, not significant. B) Protein levels of SOD1 and SOD3 were determined by Western analysis with antibodies specific to either the SOD1 or the SOD3. Representative blots are from 4 individual experiments. C) Specific activity of SOD1 and SOD3 was determined by the ratio of activity to relative amount of protein as previously described (11) . Equal protein loading was confirmed by Ponceau staining or Coomassie blue staining. The results are presented as mean ± SE from 4 separate experiments.
† P < 0.01 vs. control. NS, not significant. ) mouse fibroblasts (21) (22) (23) . SOD3 protein in the conditioned medium was adsorbed to a Cu 2+ -affinity column and eluted with an imidazole gradient (0-100 mM) as previously described (29) . The column was stripped with 50 mM EDTA, and all fractions, including the flow, were resolved by 15% acrylamide SDS/PAGE and assessed by SOD3 immunoblot analysis. B) The effect of in vitro copper treatment on SOD3-specific activity purified from Cont br and MNK br mutant cells (21) (22) (23) . Both cells were cultured in 1% serum containing DMEM for 72 h, and the cultured medium was harvested and concentrated as described in Fig. 1 . The relative SOD3 protein content was determined as described in Fig. 1 . After equal amounts of SOD3 protein were treated with or without CuCl 2 (10 µM, 60 min, at room temperature), SOD3 activity was measured. Graph shows mean data for 3 separate experiments. *P < 0.05 vs. vehicle alone. NS, not significant. , c), SOD3 (b, c), and γ-adaptin (a, b) . Right panels) Merged image from each double-labeling (×400). The γ-adaptin was used as a marker for trans-Golgi network. B) Localization of MNK and SOD3 by subcellular fractionation analysis of mouse fibroblasts. Immunoblotting of lysates was performed following discontinuous sucrose density gradient fractionation. Fifty microliters from each fraction was separated by SDS-PAGE and immunoblotted with antibodies to MNK, SOD3, γ-adaptin, and GM130. The γ-adaptin and GM130 were used as markers for trans-Golgi network and cis-Golgi, respectively. † P < 0.01 vs. nontreated cells. *P < 0.05 vs. nontreated cells. B) Two days after transient transfection with MNK cDNA, the cell lysates in CHO cells expressing V 5 -tagged SOD3 were immunoprecipitated (IP) with the antibody as indicated followed by immunoblotting (IB) with the anti-MNK antibody and the anti-V 5 antibody to detect SOD3. IgG was included as a negative control for the immunoprecipitation. C) In vitro pull-down assays using recombinant SOD3 with V 5 -His tag in mouse fibroblasts. Human recombinant SOD3 with V 5 -His tag was incubated with mouse fibroblast cell lysates, and the mixture was immunoprecipitated (IP) with anti-His antibody, followed by immunoblotting (IB) with anti-MNK, anti-Na, K-ATPase, and anti-V5 antibody. IgG was included as a negative control for the immunoprecipitation. Cell lysates were included as a positive control. (19, 20, 25) . Aortas were homogenized as previously described (28) . The activity, protein expression, and specific activity of SOD1 and SOD3 were determined as described in •-production in aortas from control littermates (Cont blo ) and blotchy MNK mutant (MNK blo ) mice as determined with lucigenin-enhanced chemiluminescence (5 µmol/l; n=5). Fresh control and MNK mutant mouse aortas were incubated with or without PEG-SOD (500 U/ml) for 30 min before assay.
† P < 0.01 vs. control mice. B) In situ detection of superoxide production with dihydroethidium (DHE) in aortas from Cont blo and MNK blo mutant mice. Freshfrozen control and MNK mutant mouse aortas were incubated with DHE for 30 min (top panels). SOD (500 U/ml) applied topically to the sequential cut sections of control and MNK mutant mouse aortas during the 30-min incubation with DHE (bottom panels). SOD abolished the fluorescence, confirming specificity of the fluorescent signal for O 2 -. Data are representative of 3 separate experiments. e, endothelium; m, media; a, adventitia. 
